EA 7379 EpiDermE, UPEC, Créteil, France.
Department of Dermatology, CH d'Argenteuil, Argenteuil, France.
J Invest Dermatol. 2021 Jan;141(1):64-71. doi: 10.1016/j.jid.2020.05.109. Epub 2020 Jun 27.
We sought to assess the quality of dermatological systematic reviews (SRs) and identify factors that predict high methodological quality. We searched for all SRs published in 2017 using PubMed, Epistemonikos, and the Cochrane Database of SRs. We included studies identified as SRs or meta-analysis in the title or abstract and dealing with a dermatological topic. Study selection and data extraction were carried out and Preferred Reporting Items for SRs and Meta-Analyses and rating by A MeaSurement Tool to Assess SRs 2 were used independently by two authors. On the basis of A MeaSurement Tool to Assess SRs 2, confidence in SRs results was classified as high, moderate, low, or very low. We included 732 studies. We described a random sample of 140. The overall rating of confidence in the results according to a tool called A MeaSurement Tool to Assess SRs 2 was high or moderate for nine reviews (6%). A total of 20 reviews (15%) had a registered protocol. Independent factors associated with moderate or high rating of A MeaSurement Tool to Assess SRs 2 were publication in a journal where Preferred Reporting Items for SRs and Meta-Analyses was mandatory (OR [95% confidence interval] = 27.0 [1.4-528]) and journal impact factor (OR of 1.9 [1.3-3]) for each increase in one more point. The observation that 90% of published dermatology SRs are of very low quality is alarming. Review registration in the International Prospective Register of SRs and full reporting according to Preferred Items for SRs and Meta-Analyses should be mandatory for publication. This study is registered in the International Prospective Register of SRs (CRD42018093856).
我们旨在评估皮肤科系统评价（SR）的质量，并确定预测高方法学质量的因素。我们使用 PubMed、Epistemonikos 和 Cochrane 系统评价数据库检索 2017 年发表的所有 SR。我们纳入了在标题或摘要中被识别为 SR 或荟萃分析且涉及皮肤科主题的研究。研究选择和数据提取由两名作者独立进行，使用的是 Preferred Reporting Items for SRs and Meta-Analyses 和 A MeaSurement Tool to Assess SRs 2。根据 A MeaSurement Tool to Assess SRs 2，SR 结果的置信度被分为高、中、低或极低。我们纳入了 732 项研究。我们描述了随机抽取的 140 项研究。根据 A MeaSurement Tool to Assess SRs 2 这一工具，9 项综述（6%）的结果置信度评级为高或中。共有 20 项综述（15%）有注册方案。与 A MeaSurement Tool to Assess SRs 2 中中等到高评级相关的独立因素包括在要求报告 Preferred Reporting Items for SRs and Meta-Analyses 的期刊上发表（OR [95%置信区间] = 27.0 [1.4-528]）和期刊影响因子（每增加一个点的 OR 为 1.9 [1.3-3]）。90%的已发表皮肤科 SR 质量非常低，这一观察结果令人震惊。SR 注册应在国际前瞻性 SR 注册库中强制进行，并且应根据 Preferred Items for SRs and Meta-Analyses 进行完整报告。本研究已在国际前瞻性 SR 注册库（CRD42018093856）中注册。
